Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation

被引:0
作者
L Fouillard
L Serfaty
J Gozlan
机构
[1] Hopital Saint Antoine AP HP,
[2] Hematologie,undefined
来源
Bone Marrow Transplantation | 2006年 / 37卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:625 / 626
页数:1
相关论文
共 18 条
[1]  
Strasser SI(1999)Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management Blood 93 1127-1136
[2]  
McDonald GB(2005)Adefovir dipivoxil for chemotherapy-induced activation of hepatitis B virus infection N Engl J Med 352 310-311
[3]  
Perez-Roldàn F(2002)Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation Hepatology 36 702-709
[4]  
Gonzàles-Carro P(2003)Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HBsAg carriers with hemato-oncological neoplasias treated with chemotherapy Leuk Lymphoma 44 759-766
[5]  
Villafànez-Garcia MC(2004)Long term efficacy and safety of Adefovir dipivoxil (ADV) 10 mg in HBe Ag+ chronic hepatitis B patients: increasing serologic, virologic and biochemical response over time (abstract) Hepatology 40 655A-undefined
[6]  
Lau GK(undefined)undefined undefined undefined undefined-undefined
[7]  
He ML(undefined)undefined undefined undefined undefined-undefined
[8]  
Fong DY(undefined)undefined undefined undefined undefined-undefined
[9]  
Bartolomeusz A(undefined)undefined undefined undefined undefined-undefined
[10]  
Au WY(undefined)undefined undefined undefined undefined-undefined